Barclays PLC Calyxt, Inc. Transaction History

Barclays PLC

  • $327 Billion
  • Q2 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$2.06 - $4.05 $2,171 - $4,268
-1,054 Closed
0 $0
Q3 2021

Nov 09, 2021
SELL
$3.18 - $5.08 $13,438 - $21,468
-4,226 Reduced 80.04%
1,054 $4,000
Q2 2021

Aug 13, 2021
SELL
$3.83 - $6.31 $12,930 - $21,302
-3,376 Reduced 39.0%
5,280 $22,000
Q1 2021

May 13, 2021
BUY
$4.25 - $12.01 $22,546 - $63,713
5,305 Added 158.31%
8,656 $52,000
Q4 2020

Feb 11, 2021
SELL
$3.21 - $5.68 $4,824 - $8,537
-1,503 Reduced 30.96%
3,351 $14,000
Q3 2020

Nov 12, 2020
SELL
$4.37 - $7.66 $4,125 - $7,231
-944 Reduced 16.28%
4,854 $26,000
Q2 2020

Aug 12, 2020
BUY
$2.9 - $6.36 $7,711 - $16,911
2,659 Added 84.71%
5,798 $29,000
Q1 2020

May 13, 2020
SELL
$2.48 - $7.85 $15,579 - $49,313
-6,282 Reduced 66.68%
3,139 $10,000
Q4 2019

Feb 10, 2020
BUY
$3.6 - $7.27 $16,725 - $33,776
4,646 Added 97.3%
9,421 $66,000
Q3 2019

Nov 14, 2019
SELL
$5.64 - $12.82 $7,535 - $17,127
-1,336 Reduced 21.86%
4,775 $27,000
Q2 2019

Aug 14, 2019
BUY
$12.24 - $17.4 $52,999 - $75,342
4,330 Added 243.12%
6,111 $76,000
Q1 2019

May 15, 2019
BUY
$10.38 - $18.97 $16,338 - $29,858
1,574 Added 760.39%
1,781 $32,000
Q4 2018

Feb 14, 2019
SELL
$9.33 - $14.99 $22,084 - $35,481
-2,367 Reduced 91.96%
207 $2,000
Q3 2018

Nov 14, 2018
BUY
$15.19 - $18.54 $22,952 - $28,013
1,511 Added 142.14%
2,574 $40,000
Q2 2018

Aug 14, 2018
SELL
$13.37 - $21.46 $60,271 - $96,741
-4,508 Reduced 80.92%
1,063 $20,000
Q1 2018

May 15, 2018
BUY
$13.12 - $26.42 $50,512 - $101,717
3,850 Added 223.71%
5,571 $73,000
Q4 2017

Feb 14, 2018
SELL
$17.13 - $31.48 $10,123 - $18,604
-591 Reduced 25.56%
1,721 $38,000
Q3 2017

Nov 14, 2017
BUY
$11.82 - $28.31 $27,327 - $65,452
2,312
2,312 $57,000

About Calyxt, Inc.

CLXT Quotes by TradingView
  • Ticker CLXT
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 46,792,100
  • Market Cap $913M
  • Description
  • Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...
More about CLXT
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email